Anna Rose Childress, PhD
University of Pennsylvania
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anna Rose Childress, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05179772 · Olanzapine in OUD PatientsUniversity of Pennsylvania · withdrawn · Opioid Use Disorder · principal investigator
- Ph2NCT03430544 · Cariprazine Effects on Brain and Behavior in Cocaine Use DisorderAnna Rose Childress, Ph.D. · terminated · Cocaine Use Disorder · principal investigator
- Ph2NCT02003664 · A Study of Baclofen ERUniversity of Pennsylvania · withdrawn · Cocaine Dependence · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.